Strategy

An innovative and very creative team

PerfuseCell team 2018

The strategy of PerfuseCell is to develop, manufacture and supply pharmaceutical industry end-users, with creative, un-conventional and visionary customized up-stream parts and rigid plastics Perfusion-Single-Use-Bioreactor products for semi-steady-state cultivation of mammalian cell lines.

PerfuseCell A/S - Cronus-PCS A/S company source ISO certified Single-Use-Bioreactor manufacturing capabilities from sister company CerCell A/S.

Its remarkable how a light weight Single-Use-Bioreactor really can ease up the life for the end-user.

PerfuseCell A/S - Cronus-PCS A/S is a daughter company of swiss Stobbe GmbH and as such a part of Stobbe Group.